Hantavirus Outbreak Sends Pharma and Biotech Stocks Surging
CNBC reported Monday that a hantavirus outbreak tied to a cruise ship sent hantavirus pharma stocks sharply higher in early trading. Moderna, Novavax, and Inovio all advanced as investors sought exposure to potential treatment and vaccine developers.
Cruise Ship Outbreak Triggers Investor Reaction
The World Health Organization first flagged the outbreak on May 2. Several passengers aboard the MV Hondius, a Dutch-flagged expedition vessel sailing the Atlantic, contracted the disease. The ship has since docked in Tenerife in Spain’s Canary Islands. Disembarkation began under strict health protocols involving testing, isolation, and coordinated repatriation efforts.
Moderna climbed roughly 7% in premarket trading after disclosing it had conducted early-stage preclinical research on hantaviruses. The work was carried out in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases. The company described the efforts as ongoing and reflective of its broader commitment to developing countermeasures against emerging infectious diseases.
Inovio Pharmaceuticals jumped approximately 11%, while Novavax gained around 5%.
Analysts Urge Caution on the Rally
Wall Street’s enthusiasm drew a swift reality check from research analysts. Evercore ISI, in a note published last week, said the commercial opportunity for Moderna is effectively negligible. Analysts described hantavirus as a structurally small, low-incidence market. They warned that any outsized move in the stock reflects retail sentiment rather than underlying fundamentals. The firm noted Moderna frequently attracts attention during outbreak headlines well beyond what commercial prospects would justify.
Evercore did acknowledge one narrow positive. The situation modestly reinforces the flexibility of Moderna’s mRNA platform, though analysts stressed that point was already widely understood following the company’s COVID-19 vaccine success.
What Is Hantavirus and How Serious Is the Threat
The specific strain involved in this outbreak is the Andes virus. It is the only known hantavirus species capable of spreading between humans, according to the WHO. As of Friday, WHO Director General Tedros Adhanom Ghebreyesus confirmed eight total cases, with three fatalities and five laboratory-confirmed infections. The WHO assessed the global public health risk as low.
President Donald Trump also addressed the situation Thursday, telling reporters the ship-based outbreak appeared to be under control and that a full report would follow shortly.
Health authorities across multiple jurisdictions continue to monitor affected individuals as repatriation efforts proceed from Tenerife.
Read Next: Fed Holds Rates Steady as Inflation Uncertainty Persists
